Literature DB >> 20096268

Thiopurines: factors influencing toxicity and response.

Alan Kambiz Fotoohi1, Sally A Coulthard, Freidoun Albertioni.   

Abstract

Thiopurines are the backbone of current anti-leukemia regimens and have also been effective immunosuppressive agents for the past half a century. Extensive research on their mechanism of action has been undertaken, yet many issues remain to be addressed to resolve unexplained cases of thiopurine toxicity or treatment failure. The aim of this review is to summarize current knowledge of the mechanism of thiopurine action in experimental models and put into context with clinical observations. Clear understanding of their metabolism will contribute to maximizing efficacy and minimizing toxicity by individually tailoring therapy according to the expression profile of relevant factors involved in thiopurine activation pathway. 2010. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20096268     DOI: 10.1016/j.bcp.2010.01.006

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  17 in total

1.  NUDT15 polymorphisms alter thiopurine metabolism and hematopoietic toxicity.

Authors:  Takaya Moriyama; Rina Nishii; Virginia Perez-Andreu; Wenjian Yang; Federico Antillon Klussmann; Xujie Zhao; Ting-Nien Lin; Keito Hoshitsuki; Jacob Nersting; Kentaro Kihira; Ute Hofmann; Yoshihiro Komada; Motohiro Kato; Robert McCorkle; Lie Li; Katsuyoshi Koh; Cesar Rolando Najera; Shirley Kow-Yin Kham; Tomoya Isobe; Zhiwei Chen; Edwynn Kean-Hui Chiew; Deepa Bhojwani; Cynthia Jeffries; Yan Lu; Matthias Schwab; Hiroto Inaba; Ching-Hon Pui; Mary V Relling; Atsushi Manabe; Hiroki Hori; Kjeld Schmiegelow; Allen E J Yeoh; William E Evans; Jun J Yang
Journal:  Nat Genet       Date:  2016-02-15       Impact factor: 38.330

2.  Inherited NUDT15 variant is a genetic determinant of mercaptopurine intolerance in children with acute lymphoblastic leukemia.

Authors:  Jun J Yang; Wendy Landier; Wenjian Yang; Chengcheng Liu; Lindsey Hageman; Cheng Cheng; Deqing Pei; Yanjun Chen; Kristine R Crews; Nancy Kornegay; F Lennie Wong; William E Evans; Ching-Hon Pui; Smita Bhatia; Mary V Relling
Journal:  J Clin Oncol       Date:  2015-01-26       Impact factor: 44.544

3.  Preclinical evaluation of NUDT15-guided thiopurine therapy and its effects on toxicity and antileukemic efficacy.

Authors:  Rina Nishii; Takaya Moriyama; Laura J Janke; Wenjian Yang; Chase C Suiter; Ting-Nien Lin; Lie Li; Kentaro Kihira; Hidemi Toyoda; Ute Hofmann; Matthias Schwab; Masatoshi Takagi; Tomohiro Morio; Atsushi Manabe; Shirley Kham; Nan Jiang; Karen R Rabin; Motohiro Kato; Katsuyoshi Koh; Allen Eng-Juh Yeoh; Hiroki Hori; Jun J Yang
Journal:  Blood       Date:  2018-03-23       Impact factor: 22.113

Review 4.  Association of NUDT15 c.415C>T allele and thiopurine-induced leukocytopenia in Asians: a systematic review and meta-analysis.

Authors:  A L Zhang; J Yang; H Wang; J L Lu; S Tang; X J Zhang
Journal:  Ir J Med Sci       Date:  2017-05-03       Impact factor: 1.568

5.  Nomenclature for alleles of the thiopurine methyltransferase gene.

Authors:  Malin L Appell; Jonathan Berg; John Duley; William E Evans; Martin A Kennedy; Lynne Lennard; Tony Marinaki; Howard L McLeod; Mary V Relling; Elke Schaeffeler; Matthias Schwab; Richard Weinshilboum; Allen E J Yeoh; Ellen M McDonagh; Joan M Hebert; Teri E Klein; Sally A Coulthard
Journal:  Pharmacogenet Genomics       Date:  2013-04       Impact factor: 2.089

Review 6.  [Research advances in pharmacogenomics of mercaptopurine].

Authors:  Xiao-Xiao Chen; Shu-Hong Shen
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2017-09

7.  Increased sensitivity to thiopurines in methylthioadenosine phosphorylase-deleted cancers.

Authors:  Sally A Coulthard; Christopher P F Redfern; Svante Vikingsson; Malin Lindqvist-Appell; Karin Skoglund; Ingrid Jakobsen-Falk; Andrew G Hall; Gordon A Taylor; Linda A Hogarth
Journal:  Mol Cancer Ther       Date:  2011-01-31       Impact factor: 6.261

Review 8.  Effect of ITPA Polymorphism on Adverse Drug Reactions of 6-Mercaptopurine in Pediatric Patients with Acute Lymphoblastic Leukemia: A Systematic Review and Meta-Analysis.

Authors:  Yeonhong Lee; Eun Jeong Jang; Ha-Young Yoon; Jeong Yee; Hye-Sun Gwak
Journal:  Pharmaceuticals (Basel)       Date:  2022-03-29

9.  Molecular insight into thiopurine resistance: transcriptomic signature in lymphoblastoid cell lines.

Authors:  Laurent Chouchana; Ana Aurora Fernández-Ramos; Florent Dumont; Catherine Marchetti; Irène Ceballos-Picot; Philippe Beaune; David Gurwitz; Marie-Anne Loriot
Journal:  Genome Med       Date:  2015-04-18       Impact factor: 11.117

Review 10.  Thiopurine S-Methyltransferase as a Pharmacogenetic Biomarker: Significance of Testing and Review of Major Methods.

Authors:  Chingiz Asadov; Gunay Aliyeva; Kamala Mustafayeva
Journal:  Cardiovasc Hematol Agents Med Chem       Date:  2017-11-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.